.png){kind=logo}
The process of separating the lighter particles of a powder from the heavier ones by means of an up- ward-directed stream of fluid (gas or liquid).
Pharmaceutics Pharmacist Competitive Exams
Q. The process of separating the lighter particles of a powder from the heavier ones by means of an up- ward-directed stream of fluid (gas or liquid).
Ans → elutriation
Explanation →
This question is taken from the test/quiz post: one liners Pharmaceutics| B.Pharmacy| Pharmacy file-4 - attemp/practice
More oneliners in - one liners Pharmaceutics| B.Pharmacy| Pharmacy file-4
Q. The process of separating the lighter particles of a powder from the heavier ones by means of an up- ward-directed stream of fluid (gas or liquid).
Ans → elutriation
Explanation →
Q. Technological process, which consists of mixing or inclusion of the therapeutic substance with an excipient or their mixtures,
Ans → embedding
Explanation →
Q. Process of enclosing a drug in a (micro or nano) particle (capsule, liposome, polymer).
Ans → encapsulation
Explanation →
Q. Non-fluid colloidal network or polymer network that is expanded throughout its whole volume by a fluid.
Ans → gel
Explanation →
Q. Solutions (aqueous or oily), emulsions, or suspensions for rectal administration of medicaments for cleansing, diagnostic, or therapeutic purposes.
Ans → enemas
Explanation →
Q. Used on tablets, granules, pellets, and capsules to make them resistant to gastric fluids but designed to disintegrate, disrupt, or dissolve when the preparation enters the duodenum.
Ans → enteric coating
Explanation →
Q. Use of products containing genetic material (e.g., pDNA, antisense DNA, si RNA) to treat a disease or condition, or to modify or manipulate the expression of genetic material or to alter the biological properties of living cells.
Ans → gene therapy
Explanation →
Q. Summary of operations carried out to convert a pharmacologically active compound into a dosage form suitable for administration.
Ans → formulation
Explanation →
Q. Powder particles, which have been aggregated to form larger irregular particles, usually of 0.5–2 mm diameter.
Ans → granules
Explanation →
Q. The Process of contact and adhesion whereby particles in dispersion form larger-size clusters.
Ans → flocculation
Explanation →
Q. Process in which powder particles are made to aggregate to larger particles called granules.
Ans → granulation
Explanation →
Q. An aqueous solution used for the prevention and treatment of mouth and throat infections.
Ans → gargle
Explanation →
Q. Pace at which a drug along with the stomach content leaves and enters the duodenum.
Ans → gastric emptying rate
Explanation →
Q. Time required for the concentration of a reactant in a given reaction to reach a value that is the arith- metic mean of its initial and final (equilibrium) values.
Ans → half life
Explanation →
Q. Crystalline form of a compound in which water molecules are part of the crystal structure.
Ans → hydrate
Explanation →
More one-liners in - Pharmaceutics
Q. Compounds that have the same molecular formula but different structural formulas
Ans → Isomer
Explanation →
Q. The distortion of a light wave due to interaction with another wave
Ans → interference
Explanation →
Q. Transfer of a drug across a membrane by a transporter (often a protein) constituent of the cytosol membrane.
Ans → carrier-mediated drug transport
Explanation →
Q. Name a technological process, which consists of mixing or inclusion of the therapeutic substance with an excipient or their mixtures, typically as a matrix dosage form, in order to change the rate of release.
Ans → embedding
Explanation →
Q. The major dietary energy sources, besides their involvement in cell structure and various other functions is
Ans → Carbohydrates
Explanation →
Q. Name the bond that forms between the hydroxyl groups of two sugar molecules
Ans → glycosidic bond
Explanation →
Q. A Biologically active substance, which when biodistributed in the body is expected to modify one or more of its functions.
Ans → drug
Explanation →
Q. The copper containing protein involved for the conversion of ferrous iron (Fe2+) to ferric iron (Fe3+) in the plasma
Ans → Ceruloplasmin
Explanation →
Q. Dosage form comprising several elements (e.g., microspheres or coated pellets) dif- fering in the rate of drug release.
Ans → multi compartment formulation
Explanation →
Q. An aqueous solution used for the prevention and treatment of mouth and throat infections.
Ans → gargle
Explanation →
Q. A substance that cannot be divded chemically into component substances.
Ans → element
Explanation →
Q. A known volumes are vacuum filtered aseptically through a membrane with a pore size small enough to trap microorganisms, which are counted after growth on plates
Ans → membrane filtration technique
Explanation →
Q. Process by which food is rendered free from pathogenic, toxigenic, and spoilage organisms.
Ans → appertization
Explanation →
Q. The third stage of acute disease, during which the number of pathogens present in the host is greatest and the signs and symptoms of disease are most severe
Ans → period of illness
Explanation →
Q. It occurs when a hydrogen atom has an electromagnetic attractive interaction with an electronegative atom.
Ans → Hydrogen Bonding
Explanation →
Q. A type of kidney infection involving the glomeruli of the nephrons
Ans → glomerulonephritis
Explanation →
Q. Science of preparation of drugs, dosage forms, and drug delivery systems taking into account the pharmacokinetics and pharmacodynamics of the drug as well as its physical and chemical properties.
Ans → pharmaceutics
Explanation →
Q. The minimum energy which reacting species must possess in order to be able to form an 'activated complex', or 'transition state', before proceeding to the products.
Ans → activation energy
Explanation →
Q. Name a substance that loses water to form a lower hydrate or becomes anhydrous spontaneously.
Ans → efflorescent
Explanation →
Q. When a mix of liquids is separated by heating it up because one liquid boils at a different temperature than the other.
Ans → distillation
Explanation →
Q. The sideways projection of a carbon-carbon single bond and the attached substituents.
Ans → sawhorse projection
Explanation →
Q. Electronegativity is a measure of the attraction an atom has for electrons.
Ans → Electronegativity
Explanation →
Q. A very strong attraction between two or more atoms that are sharing their electrons.
Ans → Covalent Bond
Explanation →
Q. Used as processing aid in tablet and capsule manufacturing, to facilitate the movement of the formulation into the dye and punch and to reduce the energy of compression.
Ans → lubricant
Explanation →
Q. The lipids that are not the structural components of biological membranes
Ans → Triacylglycerols
Explanation →
Q. Used on tablets, granules, pellets, and capsules to make them resistant to gastric fluids but designed to disintegrate, disrupt, or dissolve when the preparation enters the duodenum.
Ans → enteric coating
Explanation →
Q. Name of the peptide believed to be involved in the transport of amino acids
Ans → Glutathione
Explanation →
Q. Insertion or grafting of a biological, living, inert, or radioactive material into the body.
Ans → implantation
Explanation →
Q. a term which may be applied to any asymmetric object or molecule. The property of non-identity of an object with its mirror image
Ans → chirality
Explanation →
Q. Specific case of drug embedding in insoluble excipients (typically in a polymer) in order to achieve extended release.
Ans → matrix formulation
Explanation →
Q. Name the bean-shaped organs situated throughout the body that contain areas called germinal centers, which are rich in B and T lymphocytes
Ans → lymph nodes
Explanation →
Q. Name term that describes a solid of regular shape and the presence of three-dimensional order on the level of atomic dimensions, for a given molecule.
Ans → crystalline
Explanation →
Q. Small number of cells added to medium to start a culture is commonly called
Ans → inoculum
Explanation →
Q. Release of a drug from a dosage form that it is not immediate
Ans → modified release
Explanation →